Prostate cancer: immunotherapy offers hope
An antibody for treating advanced prostate cancer improves progression-free survival in patients with metastasised, castration-resistant prostate cancer. This is the…
prostate cancer
Prostate cancer treatment abiraterone not available
Men in England & Wales miss out on abiraterone as first-line treatment for advanced prostate cancer: The Institute of Cancer…
Test improves detection of Prostate Cancer
New screening test improves detection of Prostate Cancer using circulating tumor cells and prostate-specific markers. Melbourne-based National Institute of Medicine…
Feasibility of genetic screening for prostate cancer
Feasibility of genetic screening for prostate cancer Genetic ‘barcoding’ in GP surgeries picks out men at increased risk for…
The Continued Evolution of Prostate Cancer Screening
New data will offer a unique insight into whether prostate MRI could be the test that we are looking for…
Olaparib Outperforms Targeted Hormone Therapy in Men with Advanced Prostate Cancer
A drug used for breast and ovarian cancer is more effective than modern targeted hormone treatments at slowing progression and improving…
HIFU is effective against prostate cancer with fewer side effects
Using high energy ultrasound beams to destroy prostate cancer tumours may be as effective as surgery or radiotherapy, but with…
Stephen Fry returns to work after prostate cancer surgery
Just days after revealing he underwent surgery for prostate cancer, 60-year-old actor and TV presenter Stephen Fry has returned to…
Who’s the man?
The iconic Prostate Cancer UK man is worn by thousands of people to show they’re united in wanting to stop…
March for Men
Now in its second year, the March for Men series organised by Prostate Cancer UK has grown bigger with a…
Prostate cancer treatment under pressure
The sheer number of men being diagnosed with prostate cancer – 47,000 men were diagnosed with the disease in 2015…
Specialist nurses in prostate care feel overlooked
The important views, opinions and concerns of specialist nurses working within prostate cancer teams are not being listened to when…